Cullinan Therapeutics (CGEM) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CGEM Cullinan Therapeutics

Watchlist

12.540
+0.320+2.62%

Close Nov 22 16:00 ET

12.540
0.0000.00%

Post 16:20 ET

730.17MMarket Cap-4415P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Cullinan Therapeutics Announces Q3 2024 Progress and Outlook
TipRanksNov 20 22:58 ET
We're Not Very Worried About Cullinan Therapeutics' (NASDAQ:CGEM) Cash Burn Rate
Simply Wall StNov 19 11:22 ET
Wedbush Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $36
Moomoo NewsNov 19 09:31 ET · Ratings
JonesTrading Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Raises Target Price to $34
Moomoo NewsNov 19 03:36 ET · Ratings
Leerink Partners Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $28
Moomoo NewsNov 19 03:36 ET · Ratings
Express News | Cullinan Therapeutics Inc : Jonestrading Raises Target Price to $34 From $29
ReutersNov 19 00:58 ET

Comments

Jaguar8

Oct 16 06:38

NEWS

$Cullinan Therapeutics (CGEM.US)$
Cullinan Therapeutics Receives U.S. FDA Clearance of Investigational New Drug Application for CLN-978 Administered Subcutaneously in Patients with Moderate to Severe Systemic Lupus Erythematosus
Cullinan Therapeutics (Nasdaq: CGEM) announced FDA clearance of its Investigational New Drug (IND) Application for CLN-978, allowing its global Phase 1 clinical trial to proceed in the U.S. for patients with moderate to severe systemic lupus erythematosus (SLE). CLN-9...

Jaguar8

Apr 24 09:10

$Cullinan Therapeutics (CGEM.US)$
NEWS
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024

Moomoo Breakfast US

May 12, 2022 07:18

Columns Today's pre-market stock movers: BYND, DIS, F, GM and more

Gainers:
• $Cullinan Therapeutics (CGEM.US)$ +22.4% (Cullinan Management and Taiho Pharmaceutical to collaborate to jointly develop and commercialize CLN081/TAS6417 and Taiho's acquisition of Cullinan Pearl)
• $Lordstown Motors (RIDE.US)$ +17.2% (closes asset purchase agreement with Foxconn)
• $Applovin (APP.US)$ +15.5%(In reaction to earnings)
• $SmartRent (SMRT.US)$ +15.4%(In reaction to earnings)
• $Coupang (CPNG.US)$ +14.3%(In reaction to earn...